COVID-19 & Wellness Management
OUR SERVICES
PanoHealth is a CLIA certified laboratory providing fast turnaround COVID-19 (SARS-CoV-2) RT-PCR testing. We also offer wellness management programs assessing the evolving, real-time status of current health using protein biomarkers. We seek to better the quality of life for individuals worldwide by providing accurate and comprehensive tests and solutions.
GET IN TOUCH WITH US
PanoHealth, LLC
3607 Parkway Lane, Suite 300
Peachtree Corners, GA
30092
info@panohealth.com
(678) 387-3712
LATEST COVID NEWS
-
COVID-19 Travel Recommendations by Destination
Source: CDC Published on 2022-06-19
-
Wearing Masks in Travel and Public Transportation Settings
Source: CDC Published on 2022-05-13
-
COVID-19 Vaccines for People Vaccinated Outside the United States
Source: CDC Published on 2022-04-19
-
Frequently Asked Questions about COVID-19 Vaccination Data
Source: CDC Published on 2022-04-18
-
COVID-19 Vaccine Recommendations for Children and Teens
Source: CDC Published on 2022-04-06
-
COVID-19 Vaccine Safety in Children and Teens
Source: CDC Published on 2022-04-06
-
COVID-19 Vaccination for Children and Teens with Disabilities
Source: CDC Published on 2022-04-06
-
Find Free Masks (N95 Respirators)
Source: CDC Published on 2022-03-16
-
COVID-19 by County
Source: CDC Published on 2022-03-02
-
People of Any Age with Underlying Medical Conditions
Source: CDC Published on 2022-02-14
-
FDA Roundup: July 1, 2022
Source: FDA Published on 2022-07-01
-
FDA Infant Formula Update: June 30, 2022
Source: FDA Published on 2022-06-30
-
Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses
Source: FDA Published on 2022-06-30
-
FDA Roundup: June 28, 2022
Source: FDA Published on 2022-06-28
-
FDA Infant Formula Update: June 28, 2022
Source: FDA Published on 2022-06-28
-
FDA Introduces Innovative Proposal to Advance Consumer Access to Nonprescription Drugs
Source: FDA Published on 2022-06-27
-
FDA Infant Formula Update: June 27, 2022
Source: FDA Published on 2022-06-27
-
FDA Roundup: June 24, 2022
Source: FDA Published on 2022-06-24
-
FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS
Source: FDA Published on 2022-06-23
-
FDA Denies Authorization to Market JUUL Products
Source: FDA Published on 2022-06-23